Gastric Cancer Extracellular Vesicles Tune the Migration and Invasion of Epithelial and Mesenchymal Cells in a Histotype-Dependent Manner
Overview
Chemistry
Molecular Biology
Affiliations
Extracellular vesicles (EVs) secreted by tumor cells modulate recipient cells' behavior, but their effects in normal cells from the tumor microenvironment remain poorly known. In this study, we dissected the functional impact of gastric cancer cell-derived EVs (GC-EVs), representative of distinct GC histotypes, on the behavior of normal isogenic epithelial and mesenchymal cells. GC-EVs were isolated by differential centrifugation and characterized by transmission electron microscopy, nanoparticle tracking analysis, and imaging flow-cytometry. Epithelial and mesenchymal cells were challenged with GC-EVs and submitted to proliferation, migration, and invasion assays. Expression of epithelial and mesenchymal markers was followed by immunofluorescence and flow-cytometry. Our results indicated that GC-EVs secreted by diffuse-type cancer cells decrease the migration of recipient cells. This effect was more prominent and persistent for mesenchymal recipient cells, which also increased Fibronectin expression in response to EVs. GC-EVs secreted by cancer cells derived from tumors with an intestinal component increased invasion of recipient epithelial cells, without changes in EMT markers. In summary, this study demonstrated that GC-EVs modulate the migration and invasion of epithelial and mesenchymal cells from the tumor microenvironment, in a histotype-dependent manner, highlighting new features of intestinal and diffuse-type GC cells, which may help explaining differential metastasis patterns and aggressiveness of GC histotypes.
Wu M, Zhang Y Front Genet. 2022; 13:1012932.
PMID: 36419834 PMC: 9676937. DOI: 10.3389/fgene.2022.1012932.
Anti-Cancer Role and Therapeutic Potential of Extracellular Vesicles.
Tominaga N Cancers (Basel). 2021; 13(24).
PMID: 34944923 PMC: 8699603. DOI: 10.3390/cancers13246303.
Scarpa E, Tasini F, Crinelli R, Ceccarini C, Magnani M, Bianchi M Int J Mol Sci. 2020; 21(15).
PMID: 32751694 PMC: 7432825. DOI: 10.3390/ijms21155435.
A Novel Model of Cancer Drug Resistance: Oncosomal Release of Cytotoxic and Antibody-Based Drugs.
Eguchi T, Taha E, Calderwood S, Ono K Biology (Basel). 2020; 9(3).
PMID: 32150875 PMC: 7150871. DOI: 10.3390/biology9030047.